V Logo — 1768999
Application number
1768999
Registration number
TMA1070735
Type(s)
Design
Category
Trademark
CIPO Status
REGISTERED
TM5 status
LIVE/REGISTRATION/Issued
and Active
The trademark application has been registered with the Office.
Filed
2016-02-23
Registered
2020-01-24
Registration Expiry Date
2030-01-24
Registered Owner
Teva Pharmaceutical Industries Ltd.
124 Dvora HaNevi'a
6944020 Tel Aviv-Jaffa
ISRAEL
Agent
OSLER, HOSKIN & HARCOURT LLP
Suite 320, World Exchange Plaza
100 Queen Street
Ottawa,
ONTARIO K1P1J9
Documents
Index headings
- V
Vienna information (Code & Description)
- 25.5.5
- Backgrounds divided crosswise, vertically and horizontally
- 25.5.6
- Backgrounds divided crosswise, diagonally
- 26.4.3
- Rhombs or squares standing on one of the corners thereof
- 26.4.4
- Other irregular parallelograms, trapezia and quadrilaterals, quadrilaterals containing one or more rounded corners
- 26.4.9
- Several quadrilaterals juxtaposed, joined or intersecting
- A 26.4.24
- Quadrilaterals with dark surfaces or parts of surfaces
- 24.15.21
- Arrowheads -- Note: Not including arrowheads in the form of angles (26.3.23).
- 5.3.11
- Other leaves
- A 5.3.13
- Stylized leaves
- A 5.3.15
- Two to four leaves
- 27.3.1
- Letters or numerals representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object
- A 27.3.11
- Letters or numerals representing a plant
- 27.5.1
- Letters presenting a special form of writing
- A 27.5.21
- One letter
- 29.1.4
- Blue
- 29.1.3
- Green
Colour claim
Colour is claimed as a feature of the trademark. The colours dark blue, teal, neon green and dark green are claimed as a feature of the mark. The mark consists of two leaves. Inside each of the leaves are 4 diamond shapes. In each leaf, the top diamond is neon green, the inner middle diamond is teal, the outer middle diamond is dark green and the bottom diamond is dark blue.
Goods (Nice class & Statement)
- 5
- (1) Pharmaceutical preparations, prescription and over-the-counter, namely, acne medications, allergy medications, alopecia medications, anabolics, analgesics, anesthetics, antacids, anorectics, anthelmintics, antianaemics, anti-anaemia drugs, antianginals, antiarrhythmics, antibacterials, antibiotics, antibiotic creams and ointments, anticoagulants, anticonvulsants, antidepressants, antidiabetics, antidiarrhoeals, antidotes to counteract opioids and to treat overdoses of folic acid antagonists and iron overloading; antiemetics, anti-arthritis medications, anti-epileptics, antifibrinolytics, antiflatulents, antifungals, antigout medications, antihistamines, antihypertensives, anti-infectives, anti-inflammatories, antileprotics, antimalarials, anti-obesity medications, antiparasites, anti-parkinsonians, antipsoriasis medications, antipyretics, antirheumatic medications, anti-sickling medications, anti-smoking agents, antispasmodics, antithrombotics, antitussive medications, antiulcer medications, antivirals, appetite stimulants, appetite suppressants, asthma medications, autonomic agents, beta blockers, bone metabolism regulators, bronchodilators, burn relief medications, calcium channel blockers, calcium metabolism regulators, cancer and antineoplastic medications, central nervous system depressants, central nervous system stimulants, cough medications, cardioglycoside, cardiostimulents, cardiovascular drugs, cholagogues, cholesterol lowering agents, contraceptive medications, corticosteroids, gastro-intestinal medications, diuretics, fibrinolytics, emollients, expectorants, gastro-intestinal medications, gastroprokinetics, glaucoma medications, haemostatics, haemotological medications, hepatoprotectors, hormonal medications for use in hormone replacement therapy and in the treatment of cancer; human growth hormones; hydrocortisone, hypolipaemics, hypnotic agents, immunoglobulins, immunomodulators, immunosuppressants, impotence and sexual dysfunction medications, incontinence medications, infertility drugs, insomnia medications, insulin, iron, laxatives, liver extract, migraine medications, medications for balancing electrolytic, caloric and water levels, medications for preventing and treating sequelae of oncologic diseases and their treatment, namely, nausea and vomiting, hematologic depression, mucositis, cachexia, pain and bone pain and fatigue, medications for treating dermatological diseases and disorders, namely, dermatitis, skin and skin structure diseases, infections and injuries, psoriasis, eczema and sexually transmitted diseases, medications for treating ocular motility disorders, medications for treating neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, medications for treating obesity and weight loss and for weight management, medications for treating psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses, medications for treating renal and cardio-renal diseases, medications for preventing and treating respiratory diseases and their symptoms, medications for treating sexually transmitted diseases, mineral supplements, muscular dystrophy medications, mucolytics, muscle relaxants, multiple sclerosis medications, narcotic agents, narcotic antagonists, nasal decongestants, neuroleptics, non-steroidal anti-inflammatory drugs (NSAIDS), opiods, opthalmological drugs, otological drugs, osteoporosis medications, plasma substitutes and blood fractions, plasmodicides, psychotherapeutic and psychotropic agents, restless leg medications, sedatives, tuberculostatics, vasodilators, vasoprotective medications, vitamins, vulnerary medications, human vaccines.
- 10
- (2) Surgical instruments; dental instruments; veterinary instruments.
Services (Nice class & Statement)
- 42
- (1) Research services in the field of pharmaceuticals.
Claims
- Proposed Use in CANADA
Recordals (known also as Footnotes)
Owner Address Change / Changement d'adresse du propriétaire DATE REGISTERED / DATE DE L'ENREGISTREMENT: 2022-02-28 COMMENTS / COMMENTAIRES: Voir Preuve au dossier/See evidence on File No. 2121983Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2016-02-23 | ||
| Created | 2016-02-23 | ||
| Formalized | 2016-02-29 | ||
| Search Recorded | 2016-11-14 | ||
| Examiner's First Report | 2016-11-14 | 2017-05-14 | |
| Correspondence Created | 2016-11-18 | 2017-05-18 | |
| Correspondence Created | 2017-03-15 | 2017-09-15 | |
| Correspondence Created | 2017-08-24 | 2018-02-24 | |
| Approval Notice Sent | 2017-10-19 | 2017-11-16 | |
| Approved | 2017-12-07 | APPROVED BY PROGRAM EX200M1 | |
| Advertised | 2017-12-27 | Vol.64 Issue 3296 | |
| Allowed | 2018-04-13 | ||
| Allowance Notice Sent | 2018-04-13 | 2019-02-23 | |
| Rep for Service Changed | 2019-01-08 | From: 2520 To: 69 / Voir Preuve au dossier/See evidence on File No. 1839341 | |
| Agent Changed | 2019-01-08 | From: 2520 To: 69 / Voir Preuve au dossier/See evidence on File No. 1839341 | |
| Extension of Time | 2019-01-28 | 2019-08-23 | Online Request Date: 2019/01/28 |
| Extension of Time | 2019-06-11 | 2020-02-23 | Online Request Date: 2019/06/11 |
| Registered | 2020-01-24 | 2030-01-24 | |
| Amendment to Registration | 2022-02-28 | Owner Address Change / Voir Preuve au dossier/See evidence on File No. 2121983 |